Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial. [electronic resource]
Producer: 20111221Description: 716-24 p. digitalISSN:- 1537-6591
- Adult
- Alkynes
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active -- adverse effects
- Antitubercular Agents -- administration & dosage
- Benzoxazines -- administration & dosage
- CD4 Lymphocyte Count
- Cyclopropanes
- Female
- HIV Infections -- complications
- Humans
- India
- Liver Function Tests
- Male
- Middle Aged
- Mycobacterium tuberculosis -- isolation & purification
- Nevirapine -- administration & dosage
- Sputum -- microbiology
- Treatment Outcome
- Tuberculosis -- complications
- Viral Load
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.